ID   B95-8
AC   CVCL_1953
SY   B95.8; B 95.8; B 95-8; B-95-8; B958; GM07404; GM07404A; GM07404D
DR   BTO; BTO:0000107
DR   CLO; CLO_0001776
DR   CLO; CLO_0001838
DR   CLDB; cl364
DR   CLDB; cl365
DR   CLDB; cl366
DR   CLDB; cl367
DR   CLDB; cl368
DR   CLDB; cl369
DR   ArrayExpress; E-MTAB-1511
DR   ATCC; CRL-1612
DR   BCRJ; 0042
DR   CCRID; 3101MONGNO3
DR   CCRID; 4201MON-CCTCC00015
DR   CCRID; 5301MON-KCB93008YJ
DR   CCTCC; GDC0015
DR   ChEMBL-Cells; CHEMBL3307906
DR   ChEMBL-Targets; CHEMBL614276
DR   CLS; 305152
DR   CLS; 601102
DR   Coriell; GM07404
DR   DSMZ; ACC-100
DR   DSMZCellDive; ACC-100
DR   ECACC; 85011419
DR   IBRC; C10050
DR   ICLC; ATL95004
DR   IZSLER; BS CL 110
DR   JCRB; JCRB9123
DR   KCB; KCB 91004YJ
DR   KCB; KCB 93008YJ
DR   KCLB; 21612
DR   NCBI_Iran; C110
DR   PubChem_Cell_line; CVCL_1953
DR   TKG; TKG 0186
DR   TOKU-E; 3559
DR   Wikidata; Q54752921
RX   CelloPub=CLPUB00447;
RX   PubMed=2153236;
RX   PubMed=2824833;
RX   PubMed=3017841;
RX   PubMed=3145248;
RX   PubMed=4333982;
RX   PubMed=4346033;
RX   PubMed=4357683;
RX   PubMed=6265077;
RX   PubMed=6294325;
RX   PubMed=20454443;
RX   PubMed=24380390;
WW   https://www.phe-culturecollections.org.uk/media/139637/b95-8-cell-line-profile-v2.pdf
WW   https://www.atcc.org/en/support/technical-support/faqs/obtaining-b95-8-atcc-crl-1612-cells
WW   https://en.vircell.com/products/b95-8-cell-line/
CC   Group: Non-human primate cell line.
CC   Characteristics: Was established by exposure extracts of the 883L cell line (Cellosaurus=CVCL_6A87).
CC   Virology: This cell line sheds the Epstein-Barr virus (EBV) strain B95-8 and is often used to transform human or other primates B lymphocytes.
CC   Doubling time: ~41 hours (DSMZ=ACC-100).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: CTCF ChIP-seq epigenome analysis.
CC   Omics: YY1 ChIP-seq epigenome analysis.
CC   Discontinued: ATCC; CRL-1612; true.
CC   Discontinued: CLS; 305152; true.
CC   Discontinued: Coriell; GM07404; probable.
CC   Discontinued: KCLB; 21612; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9490; ! Saguinus oedipus (Cotton-top tamarin)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 28
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992).
//
RX   PubMed=2153236; DOI=10.1128/JVI.64.2.700-705.1990;
RA   Kobune F., Sakata H., Sugiura A.;
RT   "Marmoset lymphoblastoid cells as a sensitive host for isolation of
RT   measles virus.";
RL   J. Virol. 64:700-705(1990).
//
RX   PubMed=2824833; DOI=10.1128/JVI.61.12.4033-4037.1987;
RA   Shaw J.E., Petit R.G., Leung K.;
RT   "Growth of B95-8 cells and expression of Epstein-Barr virus lytic
RT   phase in serum-free medium.";
RL   J. Virol. 61:4033-4037(1987).
//
RX   PubMed=3017841; DOI=10.1007/BF00279094;
RA   Neitzel H.;
RT   "A routine method for the establishment of permanent growing
RT   lymphoblastoid cell lines.";
RL   Hum. Genet. 73:320-326(1986).
//
RX   PubMed=3145248;
RA   Callard R.E., Lau Y.L., Shields J.G., Smith S.H., Cairns J.A.,
RA   Flores-Romo L., Gordon J.R.;
RT   "The marmoset B-lymphoblastoid cell line (B95-8) produces and responds
RT   to B-cell growth and differentiation factors: role of shed CD23
RT   (sCD23).";
RL   Immunology 65:379-384(1988).
//
RX   PubMed=4333982; DOI=10.1073/pnas.69.2.383;
RA   Miller G., Shope T.C., Lisco H., Stitt D., Lipman M.;
RT   "Epstein-Barr virus: transformation, cytopathic changes, and viral
RT   antigens in squirrel monkey and marmoset leukocytes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 69:383-387(1972).
//
RX   PubMed=4346033; DOI=10.1073/pnas.70.1.190;
RA   Miller G., Lipman M.;
RT   "Release of infectious Epstein-Barr virus by transformed marmoset
RT   leukocytes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 70:190-194(1973).
//
RX   PubMed=4357683; DOI=10.1084/jem.138.6.1398;
RA   Miller G., Lipman M.;
RT   "Comparison of the yield of infectious virus from clones of human and
RT   simian lymphoblastoid lines transformed by Epstein-Barr virus.";
RL   J. Exp. Med. 138:1398-1412(1973).
//
RX   PubMed=6265077;
RA   Pizzo P.A., Chattopadhyay S.K., Magrath I.T., Del Giacco E.,
RA   Sherrick D., Gray T.;
RT   "Examination of Epstein-Barr virus and C-type proviral sequences in
RT   American and African lymphomas and derivative cell lines.";
RL   Cancer Res. 41:3165-3171(1981).
//
RX   PubMed=6294325; DOI=10.1128/JVI.44.3.1088-1091.1982;
RA   Skare J., Edson C., Farley J., Strominger J.L.;
RT   "The B95-8 isolate of Epstein-Barr virus arose from an isolate with a
RT   standard genome.";
RL   J. Virol. 44:1088-1091(1982).
//
RX   PubMed=20454443; DOI=10.1155/2010/904767;
RA   Uphoff C.C., Denkmann S.A., Steube K.G., Drexler H.G.;
RT   "Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in human
RT   and other primate cell lines.";
RL   J. Biomed. Biotechnol. 2010:904767.1-904767.23(2010).
//
RX   PubMed=24380390; DOI=10.1186/gb-2013-14-12-r148;
RA   Schwalie P.C., Ward M.C., Cain C.E., Faure A.J., Gilad Y., Odom D.T.,
RA   Flicek P.;
RT   "Co-binding by YY1 identifies the transcriptionally active, highly
RT   conserved set of CTCF-bound regions in primate genomes.";
RL   Genome Biol. 14:R148.1-R148.15(2013).
//